Mirador Therapeutics Funding & Investors

Mirador Therapeutics envisions precision medicine for immune-mediated inflammatory and fibrotic diseases.

Total Amount Raised: $480,000,000

Mirador Therapeutics Funding Rounds

Series A
$400,000,000
Mar 20, 2024
Series A Investors
Arch Venture Partners
Blue Owl Capital
Farallon Capital Management
Sanofi
Moore Strategic Ventures
Boxer Capital
Logos Capital
Woodline Partners
Alexandria Venture Investments
Fairmount Partners
Fidelity
TCG Crossover Management
RTW Investments
OrbiMed Advisors
Point72 Ventures
Venrock Healthcare Capital Partners
Invus Opportunities
Series Unknown
$80,000,000
Dec 13, 2023

Funding info provided by Diffbot.